Description

Ciprofibrate is a potent fibric acid derivative belonging to the class of lipid-modifying agents. It is a high-purity active pharmaceutical ingredient (API) of significant importance in the research and development of therapeutic agents for managing dyslipidemia. This compound is primarily utilized by pharmaceutical manufacturers and research institutions engaged in cardiovascular drug development and metabolic disorder studies.

Application

• Active Pharmaceutical Ingredient (API): Core component in the formulation of lipid-regulating medications.
• Pharmaceutical R&D: Critical reference standard and intermediate in the development of new fibrate-class drugs.
• Biochemical Research: Used in studies investigating peroxisome proliferator-activated receptor alpha (PPAR-α) agonist activity and lipid metabolism pathways.
• Metabolic Disorder Studies: Applied in preclinical and clinical research targeting hypertriglyceridemia and mixed dyslipidemia.
• Analytical Standard: Serves as a high-purity standard for quality control (QC) and analytical method development (e.g., HPLC, LC-MS) in pharmaceutical labs.
• Chemical Synthesis: Used as a key intermediate or precursor in the synthesis of more complex pharmaceutical molecules.

Basic Information

Product Name	Ciprofibrate
CAS No.	52214-84-3
Molecular Formula	C13H14Cl2O3
Molecular Weight	289.16 g/mol
Synonyms	2-[4-(2,2-Dichlorocyclopropyl)phenoxy]-2-methylpropanoic Acid; WIN 35833; Ciprol; Lipanor; Modalim; (RS)-2-[4-(2,2-Dichlorocyclopropyl)phenoxy]-2-methylpropionic Acid
EINECS	Contact for details

Quality Control

Our Ciprofibrate is manufactured under strict quality management systems to ensure it meets the high standards required for pharmaceutical research and development. Each batch undergoes comprehensive analytical testing, including identification, purity assay, and impurity profiling. Certificates of Analysis (COA) detailing the results are available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (typically 15-25°C). Keep the container tightly sealed to protect from moisture.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time corresponds to reference standard
Assay (HPLC)	≥98.0%
Related Substances (HPLC)	Total impurities ≤2.0% Any single impurity ≤0.5%
Loss on Drying	≤0.5%
Residue on Ignition	≤0.1%
Heavy Metals	≤20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.